文献速递咽喉与嗓音

经鼻湿化快速充气交换通气在喉显微手术中的应用与效率

Application and Efficiency of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange in Laryngeal Microsurgery.
PubMed 文献 · Laryngoscope · 2021-09-08

THRIVE组手术时间、麻醉时间和苏醒时间更短,SpO2无显著下降但TcCO2升高;声门区病变获益更明显,声门上病变无显著差异。多亚区病变和手术时间延长是术中转换通气的危险因素。

要点

  • THRIVE可安全维持喉显微手术中氧合,并缩短手术、麻醉和苏醒时间。
  • 声门区病变患者从THRIVE获益更显著,声门上病变无显著差异。
  • 多亚区病变和手术时间延长时需警惕术中转换通气方式。

核心结论

  • THRIVE在喉显微手术中能可靠维持氧合,并缩短手术和苏醒时间,从而缩短麻醉时间,尤其适用于声门区病变。
  • 当病变涉及多个亚区或手术时间延长时,使用THRIVE需谨慎。

研究设计与样本

  • 回顾性病历审查,纳入54例气管插管患者和44例THRIVE患者,均为20岁以上、无基础心、肺或脑血管疾病且接受喉显微手术者。

主要发现

  • 与ETI相比,THRIVE组手术时间缩短(16.3 ± 9.69 min vs. 21.9 ± 12.0 min),麻醉时间缩短(33.6 ± 11.4 min vs. 45.4 ± 13.9 min),苏醒时间缩短(6.73 ± 2.49 min vs. 8.52 ± 3.17 min)。
  • THRIVE组SpO2无显著下降,但TcCO2升高幅度更大(10.9 ± 6.12% vs. 7.33 ± 3.86%)。
  • 声门区病变亚组比较THRIVE与ETI得到相似结果,且差异更显著;声门上病变亚组各参数无显著差异。
  • 病变涉及多个亚区和手术时间延长是术中转换通气方式的危险因素。

临床怎么用

  • 对于声门区病变的喉显微手术,可优先考虑THRIVE以缩短手术和麻醉时间。
  • 当病变涉及多个亚区或预计手术时间较长时,应谨慎使用THRIVE并准备转换通气方式。

局限性

  • 本研究为回顾性病历审查,证据等级为3级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: This study aimed to analyze the feasibility of transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during laryngeal microsurgery (LMS) and investigated its efficiency and application according to the location of the lesion. STUDY DESIGN: Retrospective chart review. METHODS: Patients over 20 years of age who underwent LMS without underlying cardiac, pulmonary, or cerebrovascular disease were retrospectively reviewed. Overall, 54 patients with endotracheal intubation (ETI) and 44 patients with THRIVE were included. The operation and anesthesia time, induction and emergence time, oxygen saturation (SpO2 ), and transcutaneous carbon dioxide (TcCO2 ) levels were analyzed and compared between the two ventilation methods according to disease subsite. RESULTS: Compared with ETI, patients with THRIVE presented reduced operation time (16.3 ± 9.69 min vs. 21.9 ± 12.0 min), anesthesia time (33.6 ± 11.4 min vs. 45.4 ± 13.9 min), emergence time (6.73 ± 2.49 min vs. 8.52 ± 3.17 min), without significant decreases in SpO2 but with increased TcCO2 (10.9 ± 6.12% vs. 7.33 ± 3.86%). Comparing THRIVE to ETI for lesions at the glottis yielded similar findings, which were particularly more significant. However, lesions above the glottis presented no significant difference for any parameters between THRIVE and ETI groups. Lesions involving multiple subsites and prolonged operation time were risk factors for the intraoperative conversion of ventilation method. CONCLUSION: THRIVE is reliable for maintaining oxygenation during LMS and is efficient in reducing the operation and emergence times, leading to shorter anesthesia time, especially for lesions at the glottis. However, caution is required administering THRIVE, when lesion involves multiple subsites, and when operation time is prolonged. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:1061-1068, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Huh G, Min S, Cho SD, et al. Application and Efficiency of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange in Laryngeal Microsurgery. Laryngoscope. 2021. PMID: 34495557. doi:10.1002/lary.29848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。